Hyperlipemia in renal disease

Hyperlipemia in renal disease

Thesis (M.D.)--Boston University

Bibliographic Details
Main Author:	Franklin, William
Language:	en_US
Published:	Boston University 2017
Subjects:	Kidney diseases Hyperlipidemia
Online Access:	https://hdl.handle.net/2144/26008

Similar Items

Auricularia polytricha noodles prevent hyperlipemia and modulate gut microbiota in high-fat diet fed mice
by: Donglu Fang, et al.
Published: (2021-07-01)

Assessment of oxidative stress, adipocytokine secretion and carotid atherosclerosis in patients with type 2 diabetes mellitus and hyperlipemia
by: Liang Lu, et al.
Published: (2016-11-01)

The Effect of Ezetimibe on Lipid Profile and Renal Function and its Side Effects in Renal Transplant Recipients
by: Shahrzad Shahidi, et al.
Published: (2011-01-01)

Longitudinal study of BMI and Obesity as risk factors for renal graft rejection
by: Adelina Martín Salvador, et al.
Published: (2018-02-01)

Risk Factors for Chronic Kidney Disease in Older Adults with Hyperlipidemia and/or Cardiovascular Diseases in Taipei City, Taiwan: A Community-Based Cross-Sectional Analysis
by: Horng-Jinh Chang, et al.
Published: (2020-11-01)

Determination of prevalence of cardiovascular complications in end-stage renal failure patients
by: Arief Mohammad, et al.
Published: (2016-01-01)

Relations Between Diabetes, Kidney Disease and Metabolic Syndrome: Dangerous Liaisons
by: Albai Alin, et al.
Published: (2017-12-01)

STATINS IN CHRONIC KIDNEY DISEASE. IS THERE A DRUG OF CHOICE?
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function?
by: G. Pourmand, et al.
Published: (2010-07-01)

Serum lipids .. again, and always!
by: Ghassan Al-Shamma
Published: (2020-12-01)

New Pandemic: Obesity and Associated Nephropathy
by: Isha Sharma, et al.
Published: (2021-06-01)

The effects of hyperlipidemia on rotator cuff diseases: a systematic review
by: Yang Yang, et al.
Published: (2018-08-01)

Genesis of hyperlipemia in experimental nephrosis.
by: Sodhi, Harbhajan. S.
Published: (1963)

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet
by: Georgette M. Buga, et al.
Published: (2008-01-01)

Dyslipidemia in chronic renal failure patients.
by: Almeida A, et al.
Published: (1994-04-01)

Physiological risk factors for cardiovascular disease in middle-aged (40-60 years) adults and their association with dietary intake, Northern Iran
by: Simin Mouodi, et al.
Published: (2019-01-01)

Glomerular filtration rate evaluation and its comparison with international standard values in a large populationbased study
by: Seyed Javad Hoseini, et al.
Published: (2019-05-01)

Genetic and biochemical aspects of dyslipidaemias in Chinese.
Published: (2001)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation
by: G.A. Spinelli, et al.
Published: (2006-01-01)

Effects of endothelial progenitor cells transplantation on hyperlipidemia associated kidney damage in ApoE knockout mouse model
by: Piyun Gong, et al.
Published: (2020-03-01)

Sesamin Ameliorates High-Fat Diet–Induced Dyslipidemia and Kidney Injury by Reducing Oxidative Stress
by: Ruijuan Zhang, et al.
Published: (2016-05-01)

Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia
by: Müge Lutfioğlu, et al.
Published: (2017-12-01)

Serum lipids profiles in psoriatic patients
by: Maryam Azizzadeh, et al.
Published: (2010-07-01)

An Evaluation of the Numbers and Locations of Coronary Artery Disease with Some of the Major Atherosclerotic Risk Factors in Patients with Coronary Artery Disease
by: Behshad Naghshtabrizi, et al.
Published: (2017-08-01)

Hyperlipidemia: Insights into Mechanisms Involved in Modulation of Drug Pharmacokinetics and Response
by: Marwa E. Elsherbiny
Published: (2020-03-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases
by: Su-Yeon Choi, et al.
Published: (2020-05-01)

INVESTIGATIONS ON MODIFICATIONS OF LIPIDS AND PERIODONTAL PARAMETERS IN PATIENTS WITH DIABETES MELLITUS
by: Imelda Ramona DINU, et al.
Published: (2012-12-01)

Secondary hyperlipidemias: etiology and pathogenesis
by: A. I. Ershova, et al.
Published: (2019-06-01)

Effect of Silybin on Lipid Profile in Hypercholesterolaemic Rats
by: Senthil Gobalakrishnan, et al.
Published: (2016-04-01)

Effect of flaxseed powder on cardiovascular risk factor in dyslipidemic and hypertensive patients
by: Naemeh Haghighatsiar, et al.
Published: (2019-01-01)

Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia
by: Melissa A. Austin, et al.
Published: (2003-11-01)

Simple Renal Ectopia with Chronic Kidney Disease
by: Sudhanshu Ku Das, et al.
Published: (2013-01-01)

Experimental study of Pinus densiflora Siebold et Zuccarini on Hyperlipidemia and lipid in Rats
by: Kim, Dae-Hyun, et al.
Published: (2007-02-01)

Endometriosis Is Associated with an Increased Risk of Coronary Artery Disease in Asian Women
by: Pei-Chen Li, et al.
Published: (2021-09-01)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
by: Masaaki Katayama, et al.
Published: (2020-03-01)

Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism
by: Xiaolin Sun, et al.
Published: (2021-02-01)

Periodontal and Peri-Implant Diseases and Systemically Administered Statins: A Systematic Review
by: Federica Di Spirito, et al.
Published: (2021-09-01)

Oligonucleotide-Based Therapies for Renal Diseases
by: Fernando Cartón-García, et al.
Published: (2021-03-01)